LONDON--(MARKET WIRE)--Feb 8, 2008 --

8 February 2008, London, UK: Antisoma plc (LSE: ASM; USOTC: ATSMY) announces that its Chief Executive, Glyn Edwards, will be presenting at the BIO CEO & Investor Conference in New York.

The presentation is scheduled for 16:15 EST (21:15 GMT) on Tuesday, February 12th, and a webcast will be available to all on Antisoma's website at www.antisoma.com.

For live viewing of the webcast, it is recommended that viewers log on 15 minutes early in order to register and download any necessary software.

 
Enquiries:
Daniel Elger
Director of Communications
Antisoma plc
+44 7909 915 068

Brian Korb
The Trout Group
+1 212 477 9007

Background on Antisoma

Headquartered in London, UK, Antisoma is a biopharmaceutical company that develops novel products for the treatment of cancer. Antisoma fills its development pipeline by acquiring promising new product candidates from internationally recognised academic or cancer research institutions. Its core activity is the preclinical and clinical development of these drug candidates. Please visit www.antisoma.com for further information.

---END OF MESSAGE---

Copyright © Hugin AS 2008. All rights reserved.